Continuous Glucose Monitoring: TheraSense Targets Medtronic/MiniMed

TheraSense expects its continuous glucose monitoring system to compete on clinical chemistry and device size improvements in the diabetes market by mid-2004

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight